PatriciaJSimeMD

Pulmonology • Richmond, VA

Pleural Disease

Physician

Join to view full profile

Dr. Sime is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sime's full profile

Already have an account?

Office
9000 Stony Point Pkwy
Richmond, VA 23235
Phone+1 804-560-8921

Fax+1 804-560-8992

Education & Training

University of Edinburg Medical SchoolClass of 1988
University of Texas Southwestern Medical CenterFellowship, Maternal-Fetal Medicine

Certifications & Licensure

VA State Medical License 2019 - 2026
NY State Medical License 2001 - 2021
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Elected Member The American Society for Clinical Investigation, 2009

Publications & Presentations

PubMed

Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to theSpecial Issue on ILD (Part 2).
Anna J Podolanczuk, Toby M Maher, Wonder P Drake, Patricia J Sime, Oliver Eickelberg
American Journal of Respiratory and Critical Care Medicine. 2024-08-15
Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements.
Margaret A T Freeberg, Thomas H Thatcher, Sarah V Camus, Linghong Huang, John Atkinson
Physiological Reports. 2024-06-01
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to anSpecial Issue.
Toby M Maher, Anna J Podolanczuk, Wonder P Drake, Patricia J Sime, Oliver Eickelberg
American Journal of Respiratory and Critical Care Medicine. 2024-05-01

Press Mentions

Persistent Pandemics: Alum Lung Researcher Studies Long-Term Impacts for Global HealthMarch 16th, 2023
VCU to Create Institute for Liver Disease and Metabolic HealthDecember 13th, 2021
$5M Donation from Grateful Patient Helps VCU Health Expand PF CareApril 9th, 2021
Join now to see all

Grant Support

Role Of The Aryl Hydrocarbon Receptor In Lung InflammationNational Heart, Lung, And Blood Institute2008–2012
Pathways To FibrosisNational Heart, Lung, And Blood Institute2008–2009
Modulation Of Silica-Induced Pulmonary FibrosisNational Heart, Lung, And Blood Institute2005–2009
TGFB And Gene Therapy In Silica Induced Lung FibrosisNational Heart, Lung, And Blood Institute2001–2005